Optimizing Treatment of Follicular Lymphoma

EP. 1: Differential Diagnosis and Staging of Follicular Lymphoma

January 28th 2020

EP. 2: The Importance of Risk Assessment

January 28th 2020

EP. 3: When to Initiate Therapy for Follicular Lymphoma

January 28th 2020

EP. 4: Immunochemotherapy Decision Factors

January 28th 2020

EP. 5: Phase III GALLIUM Results and Maintenance Therapy

January 28th 2020

EP. 6: Determining Second-Line Therapy in FL

January 28th 2020

EP. 7: Relapsed/Refractory Treatment: The MAGNIFY Regimen

January 28th 2020

EP. 8: Treatment Options After Second-Line Relapse

January 28th 2020

EP. 9: The DYNAMO Later-Line Regimen

January 28th 2020

EP. 10: Sequencing Strategies for Later-Line Therapy

January 28th 2020

EP. 11: The Phase II EZH2 Inhibitor Trial

January 28th 2020

EP. 12: Previously Untreated FL: Obinutuzumab Plus Lenalidomide

January 28th 2020

EP. 13: The Phase III GADOLIN Trial

January 28th 2020

EP. 14: Phase Ib Polatuzumab Vedotin Trial

January 28th 2020

EP. 15: The Future Landscape of Follicular Lymphoma Treatment

January 28th 2020